Neuroone Medical Technologies: Funding, Investors & Team (Sep 2026)
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs.
Neuroone Medical Technologies has raised $22.5M across 2 funding rounds on record, the most recent a Post-IPO Debt of $10.5M announced in Aug 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Neuroone Medical Technologies Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Neuroone Medical Technologies Funding Rounds
Neuroone Medical Technologies raised $12.0M in a Post-IPO Equity announced in Oct 2021.
10 months later, a Post-IPO Debt of $10.5M was announced in Aug 2022.
Neuroone Medical Technologies Founders and Leadership Team
No contact details are on record for this team yet.
Neuroone Medical Technologies Funding Compared to Other Biotechnology Startups
Neuroone Medical Technologies' latest round of $10.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Neuroone Medical Technologies in Biotechnology and Eden Prairie
Companies Similar to Neuroone Medical Technologies
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Neuroone Medical Technologies Funding FAQs
What does Neuroone Medical Technologies do?
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs.
How much funding has Neuroone Medical Technologies raised?
Neuroone Medical Technologies has raised $22.5M across 2 rounds on record. The most recent is a Post-IPO Debt of $10.5M announced in Aug 2022.
When did Neuroone Medical Technologies last raise funding?
Neuroone Medical Technologies' most recent funding round on record is a Post-IPO Debt of $10.5M, announced in Aug 2022.
Who is the CEO of Neuroone Medical Technologies?
Dave Rosa is listed as CEO at Neuroone Medical Technologies.
Where is Neuroone Medical Technologies headquartered?
Neuroone Medical Technologies is based in Eden Prairie, Minnesota, United States.
How many employees does Neuroone Medical Technologies have?
Neuroone Medical Technologies is in the 11-50 employee band.
How does Neuroone Medical Technologies' funding compare to other Biotechnology startups?
Neuroone Medical Technologies' latest round of $10.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Neuroone Medical Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Neuroone Medical Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.